A&L Newsletter | Publication of the Regulatory Equivalence Agreement for Medications between the COFEPRIS and the ANVISA of Brazil

Publication of the Regulatory Equivalence Agreement for Medications between the COFEPRIS and the ANVISA of Brazil September 17, 2026 On September 2, 2026, the Agreement establishing General Guidelines for the application of the expedited regulatory process that grants health registrations for medications where there is equivalence of requirements, trials, and evaluation procedures as issued by…